all report title image
  • Published In : Oct 2023
  • Code : CMI4442
  • Pages : 180
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue. The main components of acellular dermal matrix include collagen and elastic fibers. Acellular dermal matrices are mostly used in breast surgery and plastic surgery. Seroma, infection, mastectomy skin necrosis, and expander/implant loss are the most commonly reported complications of acellular dermal matrices with respect to breast surgery.

Market Dynamics

The key player in the market focusing on adopting inorganic growth strategies such as acquisition and collaboration expected to drive the growth of acellular dermal matrices market over the forecast period. For instance, In December 2020, Integra Lifesciences Corporation acquired ACell, Inc., a U.S.-based biotechnology company. The acquisition helped Integra to expand its portfolio of acellular dermal matrix. Furthermore, In December 2019, Smith & Nephew Plc. Acquired Osiris Therapeutics Inc., a regenerative medicine company that offers skin, bone graft, and articular cartilage substitutes. The

acquisition helped Smith & Nephew Plc. To expand its product portfolio of acellular dermal matrix. Moreover, In April 2019, Cook Biotech, a biotechnological subsidiary of Cook Group, entered into a sales collaboration with Progressive Medical Inc., a U.S.-based medical products sales and marketing company. As a result of this sales collaboration, sales representatives employed by Progressive Medical would manage and support sales for the Cook Biotech Biodesign Hernia Graft in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the U.S. acellular dermal matrices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. acellular dermal matrices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • U.S. acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing U.S. acellular dermal matrices market

Detailed Segmentation:

  • U.S. Acellular Dermal Matrices Market, By Origin:
    • Human Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Porcine Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Bovine Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  • U.S. Acellular Dermal Matrices Market, By Application:
      • Acute Wounds
        • Burns
        • Trauma
        • Cancers
        • Infections
      • Hospitals     
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Chronic Wounds
        • Diabetic Foot Ulcers
        • Venous Leg Ulcers
        • Pressure Ulcer
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Reconstruction Procedures
        • Abdominal Wall Procedures
        • Breast Procedures
        • Orthopedic Procedures
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  • U.S. Acellular Dermal Matrices Market, By  Place of Setting
    • Hospitals
      • In- patient
      • Out- patient
    • Ambulatory Surgical Centers
    • Office Based
  • Company Profiles
    • Integra LifeSciences Corporation*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbvie Inc.
    • Johnson & Johnson
    • HansBioMed
    • Becton, Dickinson and Company
    • Cook Group
    • Smith & Nephew Plc.
    • Reprise Biomedical
    • Organogenesis Holdings Inc.
    • Tissue Regenix
    • LifeNet Health
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • MiMedx Group
    • PolyNovo Limited
    • Fidia Pharma USA Inc.
    • Baxter International Inc.
    • In2Bones Global
    • BioHorizons, Inc.
    • Harbor MedTech, Inc.
    • MLM Biologics Inc.
    • Geistlich Pharma AG
    • Olaregen Therapeutix, Inc
    • EnColl Corporation
    • Kerecis limited
    • DSM
    • ACell Inc.
    • 3M
    • Cell Constructs I, LLC
    • Marine Polymer Technologies, Inc.

‘*’ marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Origin
      • Market Snippet, By Application
      • Market Snippet, By Place of Setting
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Recent Test Launches
    • Recent Trends
    • Mergers, Acquisitions, and Collaborations
    • Product Launches/Approvals
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER’s Analysis
  4. U.S. Acellular Dermal Matrices Market - COVID-19 Impact Analysis
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. U.S. Acellular Dermal Matrices Market, By Origin, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Human Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Porcine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Bovine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  6. U.S. Acellular Dermal Matrices Market, By Application,, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Acute Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
        • Burns
        • Trauma
        • Cancers
        • Infections
    • Chronic Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
        • Diabetic Foot Ulcers
        • Venous Leg Ulcers
        • Pressure Ulcer
        • Others
    • Reconstruction Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
        • Abdominal Wall Procedures
        • Breast Procedures
        • Orthopedic Procedures
        • Others
  7. U.S. Acellular Dermal Matrices Market, By Place of Setting, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Office Based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  8. Competitive Landscape
    • Company Profiles
      • Integra LifeSciences Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • HansBioMed
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Cook Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Smith & Nephew Plc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Reprise Biomedical
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Organogenesis Holdings Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Tissue Regenix
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • LifeNet Health
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Zimmer Biomet Holdings, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Stryker Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • MiMedx Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • PolyNovo Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Fidia Pharma USA Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • In2Bones Global
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AlloSource
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
    • Analysts’ Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “U.S. Acellular Dermal Matrices Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo